Financials data is unavailable for this security.
View more
Year on year Applied DNA Sciences Inc 's revenues fell -26.43% from 18.17m to 13.37m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 8.27m to a larger loss of 9.95m.
| Gross margin | 25.04% |
|---|---|
| Net profit margin | -217.48% |
| Operating margin | -439.20% |
| Return on assets | -45.51% |
|---|---|
| Return on equity | -76.58% |
| Return on investment | -55.20% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Applied DNA Sciences Inc fell by 7.31m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 6.22m for operations while cash used for investing totalled 1.10m.
| Cash flow per share | -4.12 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.20 |
|---|---|
| Tangible book value per share | 0.9411 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.91 |
|---|---|
| Quick ratio | 3.76 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
